{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:48:02Z","timestamp":1792165682060,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chromobox protein homolog 4 (CBX4) is a component of the Polycomb group (PcG) multiprotein Polycomb repressive complexes 1 (PRC1), which is participated in several processes including growth, senescence, immunity, and tissue repair. CBX4 has been shown to have diverse, even opposite functions in different types of tissue and malignancy in previous studies. In this study, we found that CBX4 deletion promoted lung adenocarcinoma (LUAD) proliferation and progression in Kras<jats:sup>G12D<\/jats:sup> mutated background. In vitro, over 50% <jats:italic>Cbx4<\/jats:italic><jats:sup><jats:italic>L\/L<\/jats:italic><\/jats:sup><jats:italic>, Kras<\/jats:italic><jats:sup><jats:italic>G12D<\/jats:italic><\/jats:sup> mouse embryonic fibroblasts (MEFs) underwent apoptosis in the initial period after Adeno-Cre virus treatment, while a small portion of survival cells got increased proliferation and transformation abilities, which we called selected <jats:italic>Cbx4<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup><jats:italic>, Kras<\/jats:italic><jats:sup><jats:italic>G12D<\/jats:italic><\/jats:sup> cells. Karyotype analysis and RNA-seq data revealed chromosome instability and genome changes in selected <jats:italic>Cbx4<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup><jats:italic>, Kras<\/jats:italic><jats:sup><jats:italic>G12D<\/jats:italic><\/jats:sup> cells compared with <jats:italic>Kras<\/jats:italic><jats:sup><jats:italic>G12D<\/jats:italic><\/jats:sup> cells. Further study showed that P15, P16 and other apoptosis-related genes were upregulated in the primary <jats:italic>Cbx4<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup><jats:italic>, Kras<\/jats:italic><jats:sup><jats:italic>G12D<\/jats:italic><\/jats:sup> cells due to chromosome instability, which led to the large population of cell apoptosis. In addition, multiple pathways including Hippo pathway and basal cell cancer-related signatures were altered in selected <jats:italic>Cbx4<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup><jats:italic>, Kras<\/jats:italic><jats:sup><jats:italic>G12D<\/jats:italic><\/jats:sup> cells, ultimately leading to cancer. We also found that low expression of CBX4 in LUAD was associated with poorer prognosis under Kras mutation background from the human clinical data. To sum up, CBX4 deletion causes genomic instability to induce tumorigenesis under Kras<jats:sup>G12D<\/jats:sup> background. Our study demonstrates that CBX4 plays an emerging role in tumorigenesis, which is of great importance in guiding the clinical treatment of lung adenocarcinoma.<\/jats:p>","DOI":"10.1038\/s41392-023-01623-0","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:02:59Z","timestamp":1694476979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["CBX4 deletion promotes tumorigenesis under KrasG12D background by inducing genomic instability"],"prefix":"10.1038","volume":"8","author":[{"given":"Fangzhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jietian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-1773","authenticated-orcid":false,"given":"Gaobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-296X","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-6390","authenticated-orcid":false,"given":"Hongbin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6129-9902","authenticated-orcid":false,"given":"Chunmin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"1623_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12\u201327 (2012).","journal-title":"Cell"},{"key":"1623_CR2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg, A. P., Koldobskiy, M. A. & Gondor, A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat. Rev. Genet. 17, 284\u2013299 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1623_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","volume":"7","author":"AP Feinberg","year":"2006","unstructured":"Feinberg, A. P., Ohlsson, R. & Henikoff, S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21\u201333 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"1623_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","volume":"22","author":"A Piunti","year":"2021","unstructured":"Piunti, A. & Shilatifard, A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat. Rev. Mol. Cell Biol. 22, 326\u2013345 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1623_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2013.11.016","volume":"25","author":"T Cheutin","year":"2014","unstructured":"Cheutin, T. & Cavalli, G. Polycomb silencing: from linear chromatin domains to 3D chromosome folding. Curr. Opin. Genet. Dev. 25, 30\u201337 (2014).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1623_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cell.2017.08.002","volume":"171","author":"B Schuettengruber","year":"2017","unstructured":"Schuettengruber, B., Bourbon, H. M., Di Croce, L. & Cavalli, G. Genome regulation by polycomb and trithorax: 70 years and counting. Cell 171, 34\u201357 (2017).","journal-title":"Cell"},{"key":"1623_CR7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2669","volume":"20","author":"L Di Croce","year":"2013","unstructured":"Di Croce, L. & Helin, K. Transcriptional regulation by Polycomb group proteins. Nat. Struct. Mol. Biol. 20, 1147\u20131155 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1623_CR8","doi-asserted-by":"crossref","first-page":"166561","DOI":"10.1016\/j.bbadis.2022.166561","volume":"1869","author":"AAT Naqvi","year":"2023","unstructured":"Naqvi, A. A. T., Rizvi, S. A. M. & Hassan, M. I. Pan-cancer analysis of chromobox (CBX) genes for prognostic significance and cancer classification. Biochim. Biophys. Acta Mol. Basis Dis. 1869, 166561 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1623_CR9","doi-asserted-by":"crossref","first-page":"115659","DOI":"10.1016\/j.bone.2020.115659","volume":"143","author":"AJ van Wijnen","year":"2021","unstructured":"van Wijnen, A. J. et al. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development. Bone 143, 115659 (2021).","journal-title":"Bone"},{"key":"1623_CR10","doi-asserted-by":"crossref","first-page":"e80970","DOI":"10.1371\/journal.pone.0080970","volume":"8","author":"G Li","year":"2013","unstructured":"Li, G. et al. Altered expression of polycomb group genes in glioblastoma multiforme. PLoS ONE 8, e80970 (2013).","journal-title":"PLoS ONE"},{"key":"1623_CR11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.21037\/jgo-20-223","volume":"11","author":"T Ma","year":"2020","unstructured":"Ma, T. et al. Expression and prognostic value of chromobox family members in gastric cancer. J. Gastrointest. Oncol. 11, 983\u2013998 (2020).","journal-title":"J. Gastrointest. Oncol."},{"key":"1623_CR12","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.7150\/jca.44475","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. The prognostic value of the chromobox family in human ovarian cancer. J. Cancer 11, 5198\u20135209 (2020).","journal-title":"J. Cancer"},{"key":"1623_CR13","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-16-2100","volume":"76","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. CBX4 suppresses metastasis via recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma. Cancer Res. 76, 7277\u20137289 (2016).","journal-title":"Cancer Res."},{"key":"1623_CR14","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1101\/gad.1110503","volume":"17","author":"W Fischle","year":"2003","unstructured":"Fischle, W. et al. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev. 17, 1870\u20131881 (2003).","journal-title":"Genes Dev."},{"key":"1623_CR15","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.celrep.2019.02.088","volume":"26","author":"X Ren","year":"2019","unstructured":"Ren, X. et al. Maintenance of nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis. Cell Rep. 26, 3643\u20133656.e7 (2019).","journal-title":"Cell Rep."},{"key":"1623_CR16","first-page":"5503575","volume":"2022","author":"YH Chen","year":"2022","unstructured":"Chen, Y. H., Zhang, X., Ko, K. Y., Hsueh, M. F. & Kraus, V. B. CBX4 regulates replicative senescence of WI-38 fibroblasts. Oxid. Med. Cell Longev. 2022, 5503575 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1623_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1083\/jcb.201506065","volume":"212","author":"AN Mardaryev","year":"2016","unstructured":"Mardaryev, A. N. et al. Cbx4 maintains the epithelial lineage identity and cell proliferation in the developing stratified epithelium. J. Cell Biol. 212, 77\u201389 (2016).","journal-title":"J. Cell Biol."},{"key":"1623_CR18","doi-asserted-by":"crossref","first-page":"e53855","DOI":"10.15252\/embr.202153855","volume":"23","author":"L Wu","year":"2022","unstructured":"Wu, L. et al. CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2. EMBO Rep. 23, e53855 (2022).","journal-title":"EMBO Rep."},{"key":"1623_CR19","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Targeting the CK1alpha\/CBX4 axis for metastasis in osteosarcoma. Nat. Commun. 11, 1141 (2020).","journal-title":"Nat. Commun."},{"key":"1623_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2017.12.006","volume":"95","author":"JS Zeng","year":"2018","unstructured":"Zeng, J. S. et al. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling. Int. J. Biochem. Cell Biol. 95, 1\u20138 (2018).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1623_CR21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neo.2020.12.005","volume":"23","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt\/beta-catenin pathway. Neoplasia 23, 222\u2013233 (2021).","journal-title":"Neoplasia"},{"key":"1623_CR22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1242\/dev.085035","volume":"140","author":"B Liu","year":"2013","unstructured":"Liu, B. et al. Cbx4 regulates the proliferation of thymic epithelial cells and thymus function. Development 140, 780\u2013788 (2013).","journal-title":"Development"},{"key":"1623_CR23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/jcmm.14771","volume":"24","author":"C Hu","year":"2020","unstructured":"Hu, C. et al. CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer. J. Cell Mol. Med. 24, 618\u2013631 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"1623_CR24","doi-asserted-by":"crossref","first-page":"102070","DOI":"10.1016\/j.ctrv.2020.102070","volume":"89","author":"D Uprety","year":"2020","unstructured":"Uprety, D. & Adjei, A. A. KRAS: from undruggable to a druggable cancer target. Cancer Treat. Rev. 89, 102070 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"1623_CR25","doi-asserted-by":"crossref","first-page":"e37308","DOI":"10.1371\/journal.pone.0037308","volume":"7","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele. PLoS ONE 7, e37308 (2012).","journal-title":"PLoS ONE"},{"key":"1623_CR26","doi-asserted-by":"crossref","first-page":"e2026104118","DOI":"10.1073\/pnas.2026104118","volume":"118","author":"JC Tien","year":"2021","unstructured":"Tien, J. C. et al. AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer. Proc. Natl Acad. Sci. USA 118, e2026104118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1623_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","volume":"22","author":"T Tsang","year":"2020","unstructured":"Tsang, T. et al. Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma. Nat. Cell Biol. 22, 412\u2013424 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1623_CR28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","volume":"12","author":"MH Hofmann","year":"2022","unstructured":"Hofmann, M. H., Gerlach, D., Misale, S., Petronczki, M. & Kraut, N. Expanding the reach of precision oncology by drugging all KRAS mutants. Cancer Discov. 12, 924\u2013937 (2022).","journal-title":"Cancer Discov."},{"key":"1623_CR29","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","volume":"311","author":"MG Kris","year":"2014","unstructured":"Kris, M. G. et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 311, 1998\u20132006 (2014).","journal-title":"JAMA"},{"key":"1623_CR30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang, L., Guo, Z., Wang, F. & Fu, L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct. Target Ther. 6, 386 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1623_CR31","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1089\/ars.2020.8066","volume":"35","author":"CL Manrique-Caballero","year":"2021","unstructured":"Manrique-Caballero, C. L. et al. Innovations and emerging therapies to combat renal cell damage: NAD(+) as a drug target. Antioxid. Redox Signal 35, 1449\u20131466 (2021).","journal-title":"Antioxid. Redox Signal"},{"key":"1623_CR32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-023-10104-3","volume":"42","author":"J Alam","year":"2023","unstructured":"Alam, J., Huda, M. N., Tackett, A. J. & Miah, S. Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. Cancer Metastasis Rev. 42, 409\u2013425 (2023).","journal-title":"Cancer Metastasis Rev."},{"key":"1623_CR33","doi-asserted-by":"crossref","first-page":"e6380","DOI":"10.1371\/journal.pone.0006380","volume":"4","author":"GN Maertens","year":"2009","unstructured":"Maertens, G. N. et al. Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. PLoS ONE 4, e6380 (2009).","journal-title":"PLoS ONE"},{"key":"1623_CR34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nrm1443","volume":"5","author":"B Zhivotovsky","year":"2004","unstructured":"Zhivotovsky, B. & Kroemer, G. Apoptosis and genomic instability. Nat. Rev. Mol. Cell Biol. 5, 752\u2013762 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1623_CR35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4103\/0019-509X.168953","volume":"52","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Roles of Hippo signaling in lung cancer. Indian J. Cancer 52, e1\u2013e5 (2015).","journal-title":"Indian J. Cancer"},{"key":"1623_CR36","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.18632\/oncotarget.13686","volume":"8","author":"Y Dai","year":"2017","unstructured":"Dai, Y. et al. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. Oncotarget 8, 4096\u20134109 (2017).","journal-title":"Oncotarget"},{"key":"1623_CR37","first-page":"323","volume":"25","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis. Nat. Cell Biol. 25, 323\u2013336 (2023).","journal-title":"Nat. Cell Biol."},{"key":"1623_CR38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.biopha.2018.07.050","volume":"106","author":"E Chen","year":"2018","unstructured":"Chen, E. et al. MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5. Biomed. Pharmacother. 106, 1046\u20131051 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"1623_CR39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/0008-5472.CAN-19-0743","volume":"80","author":"BL Eckhardt","year":"2020","unstructured":"Eckhardt, B. L. et al. Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis. Cancer Res. 80, 1304\u20131315 (2020).","journal-title":"Cancer Res."},{"key":"1623_CR40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lungcan.2006.01.011","volume":"52","author":"CP Hsu","year":"2006","unstructured":"Hsu, C. P., Shen, G. H. & Ko, J. L. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Lung Cancer 52, 349\u2013357 (2006).","journal-title":"Lung Cancer"},{"key":"1623_CR41","doi-asserted-by":"crossref","first-page":"144223","DOI":"10.1016\/j.gene.2019.144223","volume":"726","author":"SF Khan","year":"2020","unstructured":"Khan, S. F. et al. The roles and regulation of TBX3 in development and disease. Gene 726, 144223 (2020).","journal-title":"Gene"},{"key":"1623_CR42","doi-asserted-by":"crossref","first-page":"605025","DOI":"10.3389\/fonc.2021.605025","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. FOXA2-interacting FOXP2 prevents epithelial-mesenchymal transition of breast cancer cells by stimulating E-cadherin and PHF2 transcription. Front Oncol. 11, 605025 (2021).","journal-title":"Front Oncol."},{"key":"1623_CR43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/cancers13010010","volume":"13","author":"A Paco","year":"2020","unstructured":"Paco, A., Aparecida de Bessa Garcia, S., Leitao Castro, J., Costa-Pinto, A. R. & Freitas, R. Roles of the HOX proteins in cancer invasion and metastasis. Cancers 13, 10 (2020).","journal-title":"Cancers"},{"key":"1623_CR44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.omto.2019.09.002","volume":"15","author":"R Li","year":"2019","unstructured":"Li, R. et al. CBX7 inhibits cell growth and motility and induces apoptosis in cervical cancer cells. Mol. Ther. Oncolytics 15, 108\u2013116 (2019).","journal-title":"Mol. Ther. Oncolytics"},{"key":"1623_CR45","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.2147\/OTT.S181433","volume":"11","author":"X Peng","year":"2018","unstructured":"Peng, X., Guan, L. & Gao, B. miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression. Onco Targets Ther. 11, 8865\u20138874 (2018).","journal-title":"Onco Targets Ther."},{"key":"1623_CR46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3727\/096504018X15165493852990","volume":"26","author":"Z Yongyu","year":"2018","unstructured":"Yongyu, Z., Lewei, Y., Jian, L. & Yuqin, S. [ARTICLE WITHDRAWN] MicroRNA-18a targets IRF2 and CBX7 to promote cell proliferation in hepatocellular carcinoma. Oncol. Res. 26, 1327\u20131334 (2018).","journal-title":"Oncol. Res."},{"key":"1623_CR47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-018-0562-z","volume":"11","author":"SJ Ni","year":"2018","unstructured":"Ni, S. J. et al. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-kappaB-miR-21 pathways. J. Hematol. Oncol. 11, 17 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"1623_CR48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17, 395\u2013417 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1623_CR49","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess, H., Wang, M. B. & Srivatsan, E. S. Cellular senescence and tumor suppressor gene p16. Int. J. Cancer 130, 1715\u20131725 (2012).","journal-title":"Int. J. Cancer"},{"key":"1623_CR50","doi-asserted-by":"crossref","first-page":"aad9780","DOI":"10.1126\/science.aad9780","volume":"352","author":"A Piunti","year":"2016","unstructured":"Piunti, A. & Shilatifard, A. Epigenetic balance of gene expression by Polycomb and COMPASS families. Science 352, aad9780 (2016).","journal-title":"Science"},{"key":"1623_CR51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1101\/gad.326488.119","volume":"33","author":"AJ Plys","year":"2019","unstructured":"Plys, A. J. et al. Phase separation of Polycomb-repressive complex 1 is governed by a charged disordered region of CBX2. Genes Dev. 33, 799\u2013813 (2019).","journal-title":"Genes Dev."},{"key":"1623_CR52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.molcel.2012.01.002","volume":"45","author":"Z Gao","year":"2012","unstructured":"Gao, Z. et al. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell 45, 344\u2013356 (2012).","journal-title":"Mol. Cell"},{"key":"1623_CR53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2010.12.026","volume":"144","author":"F Bantignies","year":"2011","unstructured":"Bantignies, F. et al. Polycomb-dependent regulatory contacts between distant Hox loci in Drosophila. Cell 144, 214\u2013226 (2011).","journal-title":"Cell"},{"key":"1623_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.08.040","volume":"222","author":"J Mazieres","year":"2005","unstructured":"Mazieres, J., He, B., You, L., Xu, Z. & Jablons, D. M. Wnt signaling in lung cancer. Cancer Lett. 222, 1\u201310 (2005).","journal-title":"Cancer Lett."},{"key":"1623_CR55","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/tpj.2014.21","volume":"14","author":"DJ Stewart","year":"2014","unstructured":"Stewart, D. J. et al. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 14, 509\u2013522 (2014).","journal-title":"Pharmacogenomics J."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01623-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:07:09Z","timestamp":1700298429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01623-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01623-0","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"11 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}